Your care team includes experienced surgeons, specialized bariatric nurses, registered dietitians, psychologists, and an exercise team focused on the needs of individuals with severe obesity a unique part of our program
Now, 68% of users are taking GLP1s specifically to lose weight These drugs are fundamentally disrupting how people engage with food and drink. A structural shock to grocery The research reveals a dramatic contraction in grocery purchasing among GLP1 users: 780 million has been removed from Britains grocery receipts 299 million fewer packs have been purchased User households spend 418 less per year than nonuser households More than half of users (54%) report fewer cravings and reduced food noise, while one in ten (11%) say they no longer enjoy their usual food and drink favourites
The more accurate framing involves understanding Retatrutide as a tool for managing a chronic condition rather than a cure for a temporary problem
Ideal Candidates Athletes with acute joint, ligament, or tendon injuries Post-surgical recovery (especially orthopedic procedures) Chronic tendinopathy (tennis elbow, jumper's knee, rotator cuff issues) Muscle strain recovery (especially in competitive athletes wanting faster return) Not Recommended Acute fractures (bones heal well on their own
For example, UK SmPCs for GLP-1 receptor agonists advise caution in patients with a history of pancreatitis or gallbladder disease, and include precautionary guidance regarding thyroid symptoms (such as a neck mass, difficulty swallowing, or hoarseness) that should be reported promptly
